Grant winners - 6 June 2013

National Institute for Health Research

Health Services and Delivery Research Programme

• Award winner: Jill Manthorpe
• Institution: King’s College London
• Value: £348,729

Service provision for older people who are homeless and have memory problems

Public Health Research Programme

• Award winner: Gene Feder
• Institution: University of Bristol
• Value: £193,912

An overview of interventions aimed at improving outcomes for children exposed to domestic violence

• Award winner: Nicky Stanley
• Institution: University of Central Lancashire
• Value: £161,978

Scoping the evidence on preventive interventions in domestic abuse for children and young people in the general population

Leverhulme Trust

Research Project Grants
Social sciences

• Award winner: Anthony Musson
• Institution: University of Exeter
• Value: £178,371

Law and arms: the English medieval Court of Chivalry

Philip Leverhulme Prizes
Law

• Award winner: Ioannis Lianos
• Institution: University College London
• Value: £70,000

The interaction of economic thought with the legal system

Mathematics and statistics

• Award winner: Christoph Ortner
• Institution: University of Warwick
• Value: £70,000

Numerical analysis and applied analysis

• Award winner: Lasse Rempe-Gillen
• Institution: University of Liverpool
• Value: £70,000

Complex dynamics

Medieval, early modern and modern history

• Award winner: Sadiah Qureshi
• Institution: University of Birmingham
• Value: £70,000

Modern history of race, empire and science

Arts and Humanities Research Council

Responsive Mode Grants

• Award winner: Aaron Williamon
• Institution: Royal College of Music
• Value: £802,739

Musical impact: A study of the effects of music-making on musicians’ health and well-being

• Award winner: David Parsons
• Institution: University of Wales
• Value: £774,581

The cult of saints in Wales: medieval Welsh-language sources and their transmission

In detail

Efficacy and Mechanism Evaluation Programme

Award winner: Sven Plein
Institution: University of Leeds
Value: £589,199

Coronary artery disease evaluation in rheumatoid arthritis

Rheumatoid arthritis causes disabling joint changes, but also leads to other ailments (co-morbidities), of which heart disease is the most important and risky. The reason for this excess risk is thought to be widespread inflammation in the body. Newer treatments for rheumatoid arthritis effectively suppress inflammation in the joints, and it has been speculated that these treatments may also suppress the co-morbidities, particularly reducing the risk of heart disease. The team will use magnetic resonance imaging to detect early signs of heart disease in patients with a new diagnosis of rheumatoid arthritis and to test whether these changes are reversible with effective treatments of inflammation called biologics. If such effects can be shown, the management of rheumatoid arthritis could be changed to introduce biologics.